ARLEO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 145
NA - Nord America 58
AS - Asia 21
AF - Africa 3
Totale 227
Nazione #
IT - Italia 113
US - Stati Uniti d'America 58
BG - Bulgaria 7
DE - Germania 6
SE - Svezia 6
CH - Svizzera 4
IE - Irlanda 4
PK - Pakistan 4
SG - Singapore 4
CN - Cina 3
IN - India 3
JO - Giordania 3
CI - Costa d'Avorio 2
FR - Francia 2
IR - Iran 2
FI - Finlandia 1
GB - Regno Unito 1
HK - Hong Kong 1
NG - Nigeria 1
NL - Olanda 1
TR - Turchia 1
Totale 227
Città #
Bologna 58
Milan 14
Chandler 12
Ashburn 9
Sofia 7
Berlin 5
Boydton 5
Dublin 4
Amman 3
Bern 3
Casalecchio di Reno 3
Granarolo dell'Emilia e Viadagola 3
Hyderabad 3
Parma 3
Redmond 3
Abidjan 2
Albissola Marina 2
Castel Bolognese 2
Ciampino 2
Copparo 2
Isfahan 2
Islamabad 2
Mardan 2
Naples 2
New York 2
Princeton 2
Rome 2
San Pietro di Feletto 2
Shenzhen 2
Singapore 2
Abeokuta 1
Amsterdam 1
Bremen 1
Bursa 1
Central 1
Cesena 1
Fairfield 1
Florence 1
Helsinki 1
Los Angeles 1
Mountain View 1
Olalla 1
Padova 1
Paris 1
Rimini 1
San Giorgio di Nogaro 1
San Martino Buon Albergo 1
Seattle 1
Sesto San Giovanni 1
Southend 1
Talence 1
Venice 1
Vicenza 1
Zurich 1
Totale 189
Nome #
Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of Interferon β Genes in Cancer Cells 107
Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway 73
Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies 34
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience 6
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin 6
Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience 5
The current treatment of hepatitis C 5
The Combination of Daclatasvir and Sofosbuvir for Curing Genotype 2 Patients who cannot Tolerate Ribavirin 4
Totale 240
Categoria #
all - tutte 934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 0 0 0 6 1
2022/2023130 1 1 0 11 16 5 12 28 25 5 10 16
2023/202492 5 9 2 12 12 10 7 10 2 2 9 12
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 240